Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.985
-0.015 (-0.75%)
May 15, 2026, 12:13 PM EDT - Market open

Protalix BioTherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1601451431307438
Market Cap Growth
-33.25%1.52%9.81%76.21%94.49%-69.98%
Enterprise Value
118.54121.43111.889.9283.8731.17
Last Close Price
1.991.801.881.781.370.83
PE Ratio
10.27-22.5047.0019.78-4.42-1.34
Forward PE
7.0910.293.94-60.89-
PS Ratio
2.112.742.671.981.550.99
PB Ratio
2.403.003.303.87-6.93-6.28
P/TBV Ratio
2.362.933.534.37-6.24-6.08
P/FCF Ratio
12.40-10.6219.29-52.64-2.88-3.23
P/OCF Ratio
10.68-12.0716.44-98.52-2.95-3.68
EV/Sales Ratio
1.552.302.091.371.760.81
EV/EBITDA Ratio
5.56-30.0921.417.72-7.03-1.61
EV/EBIT Ratio
5.99-22.0828.548.60-6.44-1.52
EV/FCF Ratio
9.12-8.9115.12-36.45-3.27-2.65
Debt / Equity Ratio
0.100.140.090.14-3.04-5.35
Debt / EBITDA Ratio
0.59-2.061.062.26-2.81-1.73
Debt / FCF Ratio
--0.610.75-10.65-1.31-2.85
Net Debt / Equity Ratio
-0.63-0.45-0.68-0.55-1.060.91
Net Debt / EBITDA Ratio
-2.945.44-5.61-1.57-0.950.28
Net Debt / FCF Ratio
-1.61-3.967.41-0.440.47
Asset Turnover
0.770.680.680.930.740.54
Inventory Turnover
0.901.151.211.281.131.05
Quick Ratio
1.971.471.471.090.831.28
Current Ratio
3.152.512.341.541.381.86
Return on Equity (ROE)
28.07%-14.44%7.64%72.50%179.02%166.80%
Return on Assets (ROA)
17.08%-8.32%3.50%14.48%-20.85%-28.90%
Return on Invested Capital (ROIC)
60.38%-31.29%18.15%64.49%-100.94%-209.83%
Return on Capital Employed (ROCE)
22.14%-10.62%9.04%33.60%-40.77%-186.45%
Earnings Yield
9.51%-4.44%2.13%5.06%-22.63%-74.55%
FCF Yield
8.07%-9.42%5.18%-1.90%-34.78%-31.00%
Buyback Yield / Dilution
2.19%3.10%1.66%-70.04%-9.81%-51.43%
Total Shareholder Return
2.19%3.10%1.66%-70.04%-9.81%-51.43%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q